These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31583303)

  • 1. A review of preoperative chemoradiotherapy for lower rectal cancer.
    Beppu N; Yanagi H; Tomita N
    J Anus Rectum Colon; 2017; 1(3):65-73. PubMed ID: 31583303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Otani K; Yasuda K; Murono K; Sasaki K; Watanabe T
    J Anus Rectum Colon; 2017; 1(2):39-44. PubMed ID: 31583299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and short-term outcomes of preoperative chemoradiotherapy with intermittent oral tegafur-uracil plus leucovorin in Japanese rectal cancer patients: a single center experience retrospective analysis.
    Nakagawa R; Inoue Y; Ohki T; Kaneko Y; Maeda F; Yamamoto M
    World J Surg Oncol; 2017 May; 15(1):112. PubMed ID: 28566093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reevaluation of Preoperative Chemoradiotherapy for Clinical T3 Lower Rectal Cancer: A Multicenter Collaborative Retrospective Clinical Study.
    Takeda M; Kawahara H; Ogawa M; Suwa K; Eto K; Yanaga K
    Anticancer Res; 2019 Jun; 39(6):3047-3052. PubMed ID: 31177147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
    Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
    Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer.
    Matsuda T; Sumi Y; Yamashita K; Hasegawa H; Yamamoto M; Matsuda Y; Kanaji S; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
    Int J Colorectal Dis; 2018 Apr; 33(4):367-374. PubMed ID: 29442155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative chemoradiotherapy changes the size criterion for predicting lateral lymph node metastasis in lower rectal cancer.
    Yamaoka Y; Kinugasa Y; Shiomi A; Yamaguchi T; Kagawa H; Yamakawa Y; Numata M; Furutani A
    Int J Colorectal Dis; 2017 Nov; 32(11):1631-1637. PubMed ID: 28762190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer.
    Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of pathological response to preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
    Tomono A; Yamashita K; Kanemitsu K; Sumi Y; Yamamoto M; Kanaji S; Imanishi T; Nakamura T; Suzuki S; Tanaka K; Kakeji Y
    Int J Clin Oncol; 2016 Apr; 21(2):344-349. PubMed ID: 26338272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes.
    Figueiredo N; Panteleimonitis S; Popeskou S; Cunha JF; Qureshi T; Beets GL; Heald RJ; Parvaiz A
    Eur J Surg Oncol; 2018 Apr; 44(4):484-489. PubMed ID: 29398323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of Assessing Prognostic Nutrition Index in Patients With Rectal Cancer Who Receive Preoperative Chemoradiotherapy.
    Okugawa Y; Toiyama Y; Oki S; Ide S; Yamamoto A; Ichikawa T; Kitajima T; Fujikawa H; Yasuda H; Saigusa S; Hiro J; Yoshiyama S; Kobayashi M; Araki T; Kusunoki M
    JPEN J Parenter Enteral Nutr; 2018 Aug; 42(6):998-1007. PubMed ID: 29786882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy.
    Ogura A; Akiyoshi T; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Kuroyanagi H
    World J Surg; 2017 Mar; 41(3):868-875. PubMed ID: 27730352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Chemoradiotherapy Might Improve the Prognosis of Patients with Locally Advanced Low Rectal Cancer and Lateral Pelvic Lymph Node Metastases.
    Nagasaki T; Akiyoshi T; Fujimoto Y; Konishi T; Nagayama S; Fukunaga Y; Ueno M
    World J Surg; 2017 Mar; 41(3):876-883. PubMed ID: 27730348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial.
    Li Q; Luo D; Zhu J; Yang L; Liu Q; Ma Y; Liang L; Cai S; Zhang Z; Li X;
    BMC Cancer; 2019 Nov; 19(1):1117. PubMed ID: 31729964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
    Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
    Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
    Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
    Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of successful radical resection of rectal cancer with neo-adjuvant chemoradiotherapy].
    Ami K; Kawai Y; Seki R; Gokita K; Takeuchi S; Fujiya K; Takasaki J; Amagasa H; Kamikozuru H; Ganno H; Imai K; Fukuda A; Nagahama T; Ando M; Okada Y; Tei S; Arai K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1987-9. PubMed ID: 24393988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between the Recurrence Patterns and Sizes of Lateral Pelvic Lymph Nodes before and after Chemoradiotherapy in Patients with Lower Rectal Cancer.
    Shiratori H; Kawai K; Hata K; Tanaka T; Nishikawa T; Sasaki K; Kaneko M; Murono K; Emoto S; Morikawa T; Fukayama M; Nozawa H
    Oncology; 2019; 96(1):33-43. PubMed ID: 30212816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research hotspot and progress of preoperative chemoradiotherapy for rectal cancer].
    Peng J; Pan Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):612-7. PubMed ID: 27353093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncological benefit of lateral pelvic lymph node dissection for rectal cancer treated without preoperative chemoradiotherapy: a multicenter retrospective study using propensity score analysis.
    Ishihara S; Kanemitsu Y; Murono K; Otani K; Yasuda K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Kazama S; Yamaguchi H; Sunami E; Sugihara K; Watanabe T
    Int J Colorectal Dis; 2016 Jul; 31(7):1315-21. PubMed ID: 27240821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.